Celltrion Sets Out Strategy For China

As Firm Announces Plans For A Biosimilar Launch Every Year

 
• By David Wallace
Wuhan
Celltrion Will Construct A Biologics Facility In Wuhan, China • Source: Shutterstock

More from Manufacturing

More from Business